SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-023271
Filing Date
2020-08-21
Accepted
2020-08-21 16:16:34
Documents
1
Period of Report
2020-08-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3782
  Complete submission text file 0001213900-20-023271.txt   5297
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 6275 NANCY RIDGE DRIVE, SUITE 110 SAN DIEGO CA 92121
Business Address
Murphy Keith (Reporting) CIK: 0001536583 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 201123580